With China centering domestic consumption in its economic development agenda, a sound consumer protection regime that improves consumers’ rights and builds consumer trust is necessary.
U.S. consumers spend billions every year automatically paying credit card bills for services for which they don’t realize they are being charged. This paper addresses the United States Federal Trade Commission’s attempts to regulate such negative option billing provisions, and advocates for regulations limiting the temporal scope of negative option billing for unused services.
This article explores the issues inherent in the industry through economic, legal, and social lenses–with a focus on the sterile injectable drug market–to illustrate its dangers and call for public action.